• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE JAFFÉ GEN. 2; ALKALINE PICRATE, COLORIMETRY, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE JAFFÉ GEN. 2; ALKALINE PICRATE, COLORIMETRY, CREATININE Back to Search Results
Catalog Number ASKU
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/05/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The analyzer's serial number is (b)(6).The investigation is ongoing.
 
Event or Problem Description
There was an allegation of questionable tina-quant cystatin c gen.2 and creatinine jaffé gen.2 results for 1 patient on a cobas 8000 c 701 module that were used to calculate the (gfr) glomerular filtration rate.The alleged calculated results did not fit the clinical status of the patient.Sample 1: on (b)(6) 2024 the cystatin c result was 2.65 mg/l.The calculated (gfr) glomerular filtration rate was 19.9 ml/min.Sample 2: on (b)(6) 2024 the cystatin c result was 2.38 mg/l.The calculated (gfr) glomerular filtration rate was 22.9 ml/min.The creatinine result was 0.88 mg/dl.The calculated (egfr) glomerular filtration rate was 72 ml/min.Sample 3: on (b)(6) 2024 the cystatin c result was 2.07 mg/l.The calculated (gfr) glomerular filtration rate was 27.6 ml/min.This medwatch will apply to the creatinine assay.Please refer to the medwatch with a1.Patient identifier (b)(6) for information related to the tina-quant cystatin c gen.2 assay.The samples were repeated due to the patient having no known illnesses and did not take any medication.
 
Additional Manufacturer Narrative
The calibration and qc were acceptable.Gammopathy was excluded, although the kappa free light chain and gammaglobulin results are increased, visible in the electrophoresis results.Further investigation could not be performed due to the lack of information provided and the inability to send the sample.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE JAFFÉ GEN. 2
Common Device Name
ALKALINE PICRATE, COLORIMETRY, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
indianapolis, IN 46250
MDR Report Key20416205
Report Number1823260-2024-02936
Device Sequence Number8400685
Product Code CGX
UDI-Device Identifier04015630930777
UDI-Public04015630930777
Combination Product (Y/N)Y
Initial Reporter CountryGM
PMA/510(K) Number
K951595
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 09/12/2024
Supplement Date Received by Manufacturer10/14/2024
Initial Report FDA Received Date10/10/2024
Supplement Report FDA Received Date11/05/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age60 YR
Patient SexFemale
-
-